5000124430504

The barcode 5000124430504 is associated with GlaxoSmithKline PLC's "Beconase Aqueous Nasal Spray 50mcg/200mL." This product is a prescription-only medication used to alleviate nasal congestion primarily associated with allergic reactions.

Active Ingredient: Beconase Aqueous Nasal Spray contains azelastine hydrochloride, which is an antihistamine known for its ability to relieve symptoms of allergies, specifically nasal congestion. The medication works by decreasing inflammation and swelling in the nasal passages, making it easier to breathe.

Administration: The product is delivered through a metered dose inhaler (MDI), which allows for accurate dosing when applied directly into the nostrils.

Warnings and Precautions: The product has specific warnings regarding potential allergic reactions. Users can experience symptoms such as skin rashes, itching, and in some cases, difficulty breathing. It is advised that individuals with a known history of severe allergic reactions or asthma should avoid using Beconase Aqueous Nasal Spray.

Further cautions include:

• Use with caution in individuals with nasal polyps, high blood pressure, or heart disease.
• Pregnant or breastfeeding individuals should consult a healthcare professional before using this product.

Pricing: Pricing for Beconase Aqueous Nasal Spray can vary significantly based on the region, pharmacy, and local healthcare regulations. In the United States, a typical 30-day supply ranges from $20 to $50. In the UK, where GlaxoSmithKline is headquartered, it is available by prescription, with prices generally falling between £10 and £30 (approximately $13 to $40 USD) for a single dosage.

Safety Information: While Beconase Aqueous Nasal Spray has not been linked to significant safety concerns, it is crucial for users to adhere to the recommended dosage and usage guidelines to mitigate potential side effects.

Overall, patients should consult healthcare professionals for personalized advice and to ensure the safe use of this medication.